Biogen cash flow statement
$253.40+1.17%
In fiscal 2025 (the year to 31 Dec 2025), Biogen generated $2.20B of operating cash flow and $2.05B of free cash flow, after $153.8M of capital expenditure.
From Biogen's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.
Annual
| USD | FY 2007 | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | $638.2M | $783.2M | $970.1M | $1.01B | $1.23B | $1.38B | $1.86B | $2.93B | $3.55B | $3.70B | $2.54B | $4.43B | $5.89B | $4.00B | $1.56B | $3.05B | $1.16B | $1.63B | $1.29B | $347.5M |
| Depreciation & amortization | $380.3M | $462.1M | $428.0M | $355.7M | $358.9M | $365.6M | $531.7M | $688.1M | $600.4M | $682.7M | $1.08B | $650.5M | $464.7M | $457.2M | $487.7M | $518.4M | $494.8M | $673.2M | $779.9M | $881.8M |
| Stock-based compensation | $123.1M | $146.2M | $160.9M | $167.8M | $113.0M | $118.6M | $136.3M | $155.3M | $161.4M | −$138.1M | $128.0M | $157.5M | $182.3M | $198.3M | $238.6M | $254.1M | $264.2M | $291.2M | $290.8M | $302.5M |
| Operating cash flow | $1.02B | $1.56B | $1.07B | $1.62B | $1.73B | $1.88B | $2.35B | $2.94B | $3.92B | $4.59B | $4.55B | $6.19B | $7.08B | $4.23B | $3.64B | $1.38B | $1.55B | $2.88B | $2.20B | $2.25B |
| Operating cash flow margin | 32.1% | 38.1% | 24.6% | 34.4% | 34.2% | 34.1% | 33.8% | 30.3% | 36.4% | 40.1% | 37.1% | 46.0% | 49.2% | 31.5% | 33.1% | 13.6% | 15.7% | 29.7% | 22.3% | 21.8% |
| Capital expenditures | $284.1M | $276.0M | $165.6M | $173.1M | $208.0M | $254.5M | $246.3M | $287.8M | $643.0M | $616.1M | $867.4M | $770.6M | $514.5M | $424.8M | $258.1M | $240.3M | $277.0M | $153.7M | $153.8M | $176.4M |
| Acquisitions | $95.79M | $25.00M | $0.00 | $72.48M | $5.00M | $72.40M | $15.00M | $0.00 | $198.8M | $0.00 | $0.00 | $0.00 | $744.4M | — | — | — | $6.93B | $1.07B | — | — |
| Free cash flow | $734.6M | $1.29B | $909.3M | $1.45B | $1.52B | $1.63B | $2.10B | $2.65B | $3.28B | $3.97B | $3.68B | $5.42B | $6.56B | $3.81B | $3.38B | $1.14B | $1.27B | $2.72B | $2.05B | $2.07B |
| Free cash flow margin | 23.2% | 31.4% | 20.8% | 30.8% | 30.1% | 29.5% | 30.3% | 27.4% | 30.4% | 34.7% | 30.0% | 40.3% | 45.7% | 28.3% | 30.8% | 11.2% | 12.9% | 28.1% | 20.7% | 20.1% |
| Free cash flow per share | $2.29 | $4.36 | $3.14 | $5.70 | $6.20 | $6.78 | $8.81 | $11.19 | $14.17 | $18.15 | $17.29 | $26.39 | $35.03 | $23.59 | $22.61 | $7.84 | $8.72 | $18.66 | $13.94 | $13.97 |
| Gross share repurchases | $2.99B | $738.9M | $751.2M | $2.08B | $498.0M | $984.7M | $400.3M | $886.8M | $5.00B | $1.00B | $1.37B | $4.35B | $5.87B | $6.68B | $1.80B | $750.0M | $0.00 | $0.00 | — | — |
| Stock issuance proceeds | — | — | — | — | $314.6M | $67.49M | $66.80M | $54.90M | $6.30M | $2.20M | $700.0K | $800.0K | $400.0K | $700.0K | — | — | — | — | — | — |
| Net share repurchases | $2.99B | $738.9M | $751.2M | $2.08B | $183.3M | $917.2M | $333.5M | $831.9M | $4.99B | $997.8M | $1.36B | $4.35B | $5.87B | $6.68B | $1.80B | $750.0M | $0.00 | $0.00 | — | — |
| Cash interest paid | $35.44M | $40.00M | $68.10M | $68.10M | $66.70M | $65.40M | $53.60M | $41.20M | $39.10M | $281.2M | $281.7M | $243.2M | $244.2M | $272.7M | $280.8M | $262.5M | $252.2M | $245.4M | $264.1M | — |
| Free cash flow after SBC | $611.5M | $1.14B | $748.4M | $1.28B | $1.41B | $1.51B | $1.96B | $2.50B | $3.12B | $3.83B | $3.56B | $5.26B | $6.38B | $3.61B | $3.14B | $889.9M | $1.01B | $2.43B | $1.76B | $1.77B |
Quarterly
| USD | Q4 FY2023 | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | $249.7M | $393.4M | $583.6M | $388.5M | $266.7M | $240.5M | $634.8M | $466.5M | −$48.90M | $319.5M | $97.50M | −$20.60M |
| Depreciation & amortization | $140.1M | $147.5M | $158.8M | $182.8M | $184.0M | $183.2M | $194.3M | $202.2M | $200.2M | $204.4M | $236.1M | $241.1M |
| Stock-based compensation | $54.90M | $72.80M | $70.60M | $72.70M | $75.10M | $81.00M | $74.90M | $75.30M | $59.60M | $84.00M | $77.40M | $81.50M |
| Operating cash flow | $12.50M | $553.2M | $625.8M | $935.6M | $760.9M | $259.3M | $160.9M | $1.27B | $511.9M | $645.5M | $448.9M | $640.8M |
| Operating cash flow margin | 0.5% | 24.2% | 25.4% | 37.9% | 31.0% | 10.7% | 6.1% | 50.2% | 22.5% | 26.1% | 16.4% | 22.9% |
| Capital expenditures | $65.20M | $45.90M | $33.50M | $35.00M | $39.30M | $37.10M | $26.60M | $46.20M | $43.90M | $51.20M | $40.90M | $40.40M |
| Acquisitions | $590.5M | — | — | — | $0.00 | — | — | — | — | — | — | — |
| Free cash flow | −$52.70M | $507.3M | $592.3M | $900.6M | $721.6M | $222.2M | $134.3M | $1.23B | $468.0M | $594.3M | $408.0M | $600.4M |
| Free cash flow margin | −2.2% | 22.1% | 24.0% | 36.5% | 29.4% | 9.1% | 5.1% | 48.4% | 20.5% | 24.0% | 14.9% | 21.4% |
| Free cash flow per share | −$0.36 | $3.48 | $4.06 | $6.16 | $4.96 | $1.52 | $0.92 | $8.34 | $3.16 | $4.00 | $2.74 | $4.06 |
| Gross share repurchases | $0.00 | — | — | — | — | — | — | — | — | — | — | — |
| Net share repurchases | $0.00 | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow after SBC | −$107.6M | $434.5M | $521.7M | $827.9M | $646.5M | $141.2M | $59.40M | $1.15B | $408.4M | $510.3M | $330.6M | $518.9M |
The main figures as JSON and plain text. See data and methodology.
BIIB in the terminal
Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.
